AdaptHealth Corp. (AHCO) stock soared 23.04% in Tuesday's pre-market trading session, driven by the company's impressive fourth-quarter 2024 financial results and positive outlook for 2025.
The medical equipment and services provider reported better-than-expected Q4 earnings, with net revenue of $856.65 million, beating the analyst consensus estimate of $829.19 million. AdaptHealth's net income of $51.4 million and earnings per share of $0.34 also exceeded Wall Street expectations, reflecting strong demand for the company's products and services.
The strong financial performance was backed by AdaptHealth's strategic initiatives, such as its "One Adapt" program aimed at enhancing operational efficiency and increasing clinical relevance. The company's focus on accelerating the application of AI and automation also contributed to its positive results.
Looking ahead, AdaptHealth provided an optimistic outlook for fiscal 2025, forecasting net revenue in the range of $3.22 billion to $3.36 billion, surpassing analysts' estimates of $3.33 billion. The company also expects to generate Adjusted EBITDA between $670 million and $710 million, and free cash flow ranging from $180 million to $220 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.